...
首页> 外文期刊>Biochemical Pharmacology >4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90 alpha chaperone activity against prostate cancer
【24h】

4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90 alpha chaperone activity against prostate cancer

机译:4-羟基苯甲酸衍生物作为 HDAC6 特异性抑制剂调节微管结构和 HSP90 α 伴侣活性对抗前列腺癌

获取原文
获取原文并翻译 | 示例
           

摘要

Histone deacetylase (HDAC)6 is a unique isoenzyme targeting specific substrates including a-tubulin and heat shock protein (HSP)90. HDAC6 is involved in protein trafficking and degradation, cell shape and migration. Deregulation of HDAC6 activity is associated with a variety of diseases including cancer leading to a growing interest for developing HDAC6 inhibitors. Here, we identified two new structurally related 4-hydroxybenzoic acids as selective HDAC6 inhibitors reducing proliferation, colony and spheroid formation as well as viability of prostate cancer cells. Both compounds strongly enhanced alpha-tubulin acetylation leading to remodeling of microtubular organization. Furthermore, 4-hydroxybenzoic acids decreased HSP90 alpha regulation of the human androgen receptor in prostate cancer cells by increasing HSP90 alpha acetylation levels. Collectively, our data support the potential of 4-hydroxybenzoic acid derivatives as HDAC6-specific inhibitors with anti-cancer properties. (C) 2015 Elsevier Inc. All rights reserved.
机译:组蛋白脱乙酰酶 (HDAC)6 是一种独特的同工酶,靶向特定底物,包括 α-微管蛋白和热休克蛋白 (HSP)90。HDAC6 参与蛋白质运输和降解、细胞形状和迁移。HDAC6活性的失调与包括癌症在内的多种疾病有关,导致人们对开发HDAC6抑制剂的兴趣日益浓厚。在这里,我们鉴定了两种新的结构相关的 4-羟基苯甲酸作为选择性 HDAC6 抑制剂,可减少前列腺癌细胞的增殖、集落和球状体形成以及活力。这两种化合物都强烈增强了α-微管蛋白乙酰化,导致微管组织的重塑。此外,4-羟基苯甲酸通过增加 HSP90 α 乙酰化水平来降低前列腺癌细胞中人雄激素受体的 HSP90 α 调节。总的来说,我们的数据支持4-羟基苯甲酸衍生物作为具有抗癌特性的HDAC6特异性抑制剂的潜力。(C) 2015 爱思唯尔公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号